FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361008056> ?p ?o ?g. }

• W4361008056 abstract "Abstract Background The military has used topical hemostatic agents to successfully treat life‐threatening external bleeding for years. In contrast to the military environment, the general population are increasingly prescribed anticoagulants. There are only few comparative evaluations of topical hemostatic agents with anticoagulated human blood. It is important to understand the impact of these agents on those who take anticoagulants. Study design and Methods Citrated blood of patients treated with enoxaparin, heparin, and acetylsalicylic acid, apixaban or phenprocoumon was incubated with different hemostatic agents (QuikClot Gauze, Celox Granules, Celox Gauze, Chito SAM 100, WoundClot Trauma Gauze, QuikClot Gauze Moulage Trainer and Kerlix) and rotational thromboelastometry was performed with non‐activated thromboelastometry (NATEM reagent). Results All tested agents improved the onset of coagulation in all anticoagulants, mostly to a significant degree. Most significant improvements were produced by QuikClot Gauze and QuikClot Gauze Moulage Trainer, followed by the tested chitosans (Celox Granules, Celox Gauze, Chito SAM 100). Of the anticoagulant groups, the most significant improvements were seen in enoxaparin. This was followed in order by apixaban, heparin, and acetylsalicylic acid, and phenprocoumon. Discussion All the hemostatic agents tested were able to activate the clotting cascade earlier and initiate faster clot formation in anticoagulated blood. A definitive head‐to‐head comparison is not feasible, because of the limitations of an in‐vitro analysis. However, the sometimes‐presented hypothesis that kaolin‐based hemostatic agents are ineffective in anticoagulated blood is inaccurate according to our data. Hemostasis with hemostatic agents appears most challenging with phenprocoumon." @default.
• W4361008056 created "2023-03-30" @default.
• W4361008056 creator A5002699239 @default.
• W4361008056 creator A5030382418 @default.
• W4361008056 creator A5032951685 @default.
• W4361008056 creator A5044202192 @default.
• W4361008056 creator A5059480753 @default.
• W4361008056 creator A5061767390 @default.
• W4361008056 creator A5068177825 @default.
• W4361008056 date "2023-04-26" @default.
• W4361008056 modified "2023-10-06" @default.
• W4361008056 title "Hemostatics in patients with inhibited coagulation—A viscoelastic in‐vitro analysis" @default.
• W4361008056 cites W1591738935 @default.
• W4361008056 cites W1972019849 @default.
• W4361008056 cites W1991130709 @default.
• W4361008056 cites W1991813496 @default.
• W4361008056 cites W2009879449 @default.
• W4361008056 cites W2018114099 @default.
• W4361008056 cites W2018408256 @default.
• W4361008056 cites W2090248107 @default.
• W4361008056 cites W2104285543 @default.
• W4361008056 cites W2116485327 @default.
• W4361008056 cites W2125822824 @default.
• W4361008056 cites W2134422533 @default.
• W4361008056 cites W2150100219 @default.
• W4361008056 cites W2171308886 @default.
• W4361008056 cites W2187804460 @default.
• W4361008056 cites W2289117300 @default.
• W4361008056 cites W2512206082 @default.
• W4361008056 cites W2565613466 @default.
• W4361008056 cites W2616237281 @default.
• W4361008056 cites W2626180262 @default.
• W4361008056 cites W2762094720 @default.
• W4361008056 cites W2799439589 @default.
• W4361008056 cites W2806552410 @default.
• W4361008056 cites W2906464836 @default.
• W4361008056 cites W2913138656 @default.
• W4361008056 cites W2941683809 @default.
• W4361008056 cites W2970852188 @default.
• W4361008056 cites W3096361531 @default.
• W4361008056 cites W3141807812 @default.
• W4361008056 cites W3197408625 @default.
• W4361008056 cites W4205294761 @default.
• W4361008056 cites W4210917725 @default.
• W4361008056 cites W4211237975 @default.
• W4361008056 cites W4220693618 @default.
• W4361008056 doi "https://doi.org/10.1111/trf.17333" @default.
• W4361008056 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36971054" @default.
• W4361008056 hasPublicationYear "2023" @default.
• W4361008056 type Work @default.
• W4361008056 citedByCount "0" @default.
• W4361008056 crossrefType "journal-article" @default.
• W4361008056 hasAuthorship W4361008056A5002699239 @default.
• W4361008056 hasAuthorship W4361008056A5030382418 @default.
• W4361008056 hasAuthorship W4361008056A5032951685 @default.
• W4361008056 hasAuthorship W4361008056A5044202192 @default.
• W4361008056 hasAuthorship W4361008056A5059480753 @default.
• W4361008056 hasAuthorship W4361008056A5061767390 @default.
• W4361008056 hasAuthorship W4361008056A5068177825 @default.
• W4361008056 hasBestOaLocation W43610080561 @default.
• W4361008056 hasConcept C126322002 @default.
• W4361008056 hasConcept C141071460 @default.
• W4361008056 hasConcept C1621761 @default.
• W4361008056 hasConcept C26809991 @default.
• W4361008056 hasConcept C2775876007 @default.
• W4361008056 hasConcept C2776301958 @default.
• W4361008056 hasConcept C2777557582 @default.
• W4361008056 hasConcept C2777664302 @default.
• W4361008056 hasConcept C2778205648 @default.
• W4361008056 hasConcept C2778382381 @default.
• W4361008056 hasConcept C2778589496 @default.
• W4361008056 hasConcept C2778661090 @default.
• W4361008056 hasConcept C2779161974 @default.
• W4361008056 hasConcept C2780638905 @default.
• W4361008056 hasConcept C2908647359 @default.
• W4361008056 hasConcept C42219234 @default.
• W4361008056 hasConcept C71924100 @default.
• W4361008056 hasConcept C77171857 @default.
• W4361008056 hasConcept C98274493 @default.
• W4361008056 hasConcept C99454951 @default.
• W4361008056 hasConceptScore W4361008056C126322002 @default.
• W4361008056 hasConceptScore W4361008056C141071460 @default.
• W4361008056 hasConceptScore W4361008056C1621761 @default.
• W4361008056 hasConceptScore W4361008056C26809991 @default.
• W4361008056 hasConceptScore W4361008056C2775876007 @default.
• W4361008056 hasConceptScore W4361008056C2776301958 @default.
• W4361008056 hasConceptScore W4361008056C2777557582 @default.
• W4361008056 hasConceptScore W4361008056C2777664302 @default.
• W4361008056 hasConceptScore W4361008056C2778205648 @default.
• W4361008056 hasConceptScore W4361008056C2778382381 @default.
• W4361008056 hasConceptScore W4361008056C2778589496 @default.
• W4361008056 hasConceptScore W4361008056C2778661090 @default.
• W4361008056 hasConceptScore W4361008056C2779161974 @default.
• W4361008056 hasConceptScore W4361008056C2780638905 @default.
• W4361008056 hasConceptScore W4361008056C2908647359 @default.
• W4361008056 hasConceptScore W4361008056C42219234 @default.
• W4361008056 hasConceptScore W4361008056C71924100 @default.
• W4361008056 hasConceptScore W4361008056C77171857 @default.
• W4361008056 hasConceptScore W4361008056C98274493 @default.
• W4361008056 hasConceptScore W4361008056C99454951 @default.

• next